About MyFirstApp Sweden AB 
MyFirstApp Sweden AB
Pharmaceuticals & Biotechnology
ObsteCare AB is a Sweden-based provider of solutions within area of childbirth care. The Company is a developer of Amniotic Fluid Lactate (AFL) method, which aims to measure lactic acid content in the fetal water. Samples of amniotic fluid are collected and analyzed for the concentration of lactate. The lactate level is automatically presented in the partogram. By combining the result with the development of cervix dilatation a thorough understanding of the delivery status is obtained. The fluid is collected with a standard syringe. The fluid is delivered into the single use measuring probe on the measuring unit and the measurement starts automatically. The method is used by clinics primarily in the Nordic countries, the United Kingdom and the Baltic States.
Company Coordinates 
Company Details
Fogdevreten 2 , SOLNA None : 171 65
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2025)
Net Profit:
-1 Million
Pharmaceuticals & Biotechnology
SEK 164 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.01
-444.23%
49.68






